Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Principal Formulation Development Scientist I - Oxford
Scientist - Infectious Diseases - Oxford
ImmunocoreHenley on Thames
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreStratfield SayeScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUnited KingdomScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreOxfordSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreStratfield SayeSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
